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Metabolic Requirements of Escherichia coli in Intracellular Bacterial
Communities during Urinary Tract Infection Pathogenesis
Matt S. Conover, Maria Hadjifrangiskou,* Joseph J. Palermo,* Michael E. Hibbing, Karen W. Dodson, Scott J. Hultgren
Department of Molecular Microbiology and Center for Women’s Infectious Disease Research, Washington University School of Medicine, St. Louis, Missouri, USA
* Present address: Maria Hadjifrangiskou, Department of Pathology, Microbiology & Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Joseph J.
Palermo, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA.

ABSTRACT Uropathogenic Escherichia coli (UPEC) is the primary etiological agent of over 85% of community-acquired
urinary tract infections (UTIs). Mouse models of infection have shown that UPEC can invade bladder epithelial cells in a
type 1 pilus-dependent mechanism, avoid a TLR4-mediated exocytic process, and escape into the host cell cytoplasm. The
internalized UPEC can clonally replicate into biofilm-like intracellular bacterial communities (IBCs) of thousands of bacteria while avoiding many host clearance mechanisms. Importantly, IBCs have been documented in urine from women and
children suffering acute UTI. To understand this protected bacterial niche, we elucidated the transcriptional profile of bacteria within IBCs using microarrays. We delineated the upregulation within the IBC of genes involved in iron acquisition,
metabolism, and transport. Interestingly, lacZ was highly upregulated, suggesting that bacteria were sensing and/or utilizing a galactoside for metabolism in the IBC. A ⌬lacZ strain displayed significantly smaller IBCs than the wild-type strain
and was attenuated during competitive infection with a wild-type strain. Similarly, a galK mutant resulted in smaller IBCs
and attenuated infection. Further, analysis of the highly upregulated gene yeaR revealed that this gene contributes to oxidative stress resistance and type 1 pilus production. These results suggest that bacteria within the IBC are under oxidative
stress and, consistent with previous reports, utilize nonglucose carbon metabolites. Better understanding of the bacterial
mechanisms used for IBC development and establishment of infection may give insights into development of novel antivirulence strategies.
IMPORTANCE Urinary tract infections (UTIs) are one of the most common bacterial infections, impacting mostly women. Every
year, millions of UTIs occur in the U.S. with most being caused by uropathogenic E. coli (UPEC). During a UTI, UPEC invade
bladder cells and form an intracellular bacterial community (IBC) that allows for the bacteria to replicate protected from the
host immune response. In this study, we investigated genes that are expressed by UPEC within the IBC and determined how they
contribute to the formation of this specialized community. Our findings suggest that galactose is important for UPEC growth in
the IBC. Additionally, we found that a gene involved in oxidative stress is also important in the regulation of a key factor needed
for UPEC invasion of bladder cells. These results may open the door for the development of treatments to diminish UTI frequency and/or severity.
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U

ropathogenic Escherichia coli (UPEC) accounts for over 85%
of reported community-acquired urinary tract infections
(UTI) (1). These painful and economically costly infections
affect approximately 50% of women at least once during their
lifetime (2). In the murine cystitis model, initial colonization is
dependent upon the mannose-binding adhesin, FimH, at the
tip of type 1 pili (3). FimH binds to mannosylated glycoproteins on the superficial umbrella cells of the urothelium, mediating colonization and triggering subsequent bacterial internalization into the bladder epithelial cells (4, 5). Once inside
the epithelial cells, UPEC bacteria are protected from host innate immune defenses, and a single bacterium can replicate to
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104 or more bacteria within hours after invasion, forming
biofilm-like intracellular bacterial communities (IBCs) (6, 7).
Similarly to extracellular biofilms, IBC formation is transient
and terminates in a dispersal stage, during which bacteria filament and escape the infected host cells, spreading to neighboring (naive) host cells, where the IBC cycle can be repeated (8).
Numerous host defenses against this process, including inflammasome activation and programed urothelial exfoliation and
bacterial expulsion via a TRPML3-mediated mechanism, have
been uncovered (9–11).
IBCs and bacterial filaments have been documented in urine
from women suffering acute UTI 1 to 2 days after sexual inter®
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course but not in healthy controls or infections caused by Grampositive organisms, which do not form IBCs (12). In children, the
presence of IBCs was predictive of future recurrences (13, 14).
Mouse model studies have shown that the ability of UPEC strains
to form IBCs allows UPEC to persist in the face of a stringent
population bottleneck during acute cystitis, leading to a range of
infection outcomes such as the formation of quiescent intracellular reservoirs (QIRs) or the development of chronic cystitis, which
is characterized by persistent high-titer bacteriuria (⬎104 CFU/
ml) and high-titer bacterial bladder burdens (⬎104 CFU) 2 or
more weeks after inoculation, accompanied by chronic inflammation (7, 15). During chronic cystitis, luminal bacterial replication
is accompanied by persistent lymphoid aggregates in the bladder
lamina propria and urothelial hyperplasia with a lack of superficial
facet cell terminal differentiation (15). The same histological findings of submucosal lymphoid aggregates and urothelial hyperplasia have been observed in humans suffering persistent bacteriuria
(16). Additionally, similarly to what is seen in mice, soluble biomarkers engaged in myeloid cell development and chemotaxis
were discovered that are predictive of future UTI recurrence under conditions in which levels are elevated in the sera of young
women with UTI (16). These studies demonstrated the ability of
the chronic cystitis model to reflect and predict findings related to
recurrent UTI (rUTI) risk in women. Collectively, these studies
indicated that observations made in murine infection models provide insights into human infection. Therefore, thoroughly understanding the bacterial mechanisms important in mouse models of
UTI is highly likely to give important insights for designing antibiologics with antibiotic-sparing therapeutic potential in treating
and preventing clinical UTI.
In murine models of infection, approximately 107 bacteria are
transurethrally instilled in the bladder (17, 18). Of these, only
about 1,000 to 10,000 bacteria become internalized, and only ~1%
of internalized bacteria escape into the cytoplasm and initiate the
IBC cascade (7). Factors that lead to bottlenecks during the course
of infection contribute to reductions in the diversity of the initial
bacterial inoculum. These factors include micturition, exfoliation,
expulsion, and the innate immune response (9, 10, 16). Such bottlenecks prevent the use of large-scale in vivo transposon screens to
identify factors involved in mediating IBC expansion and UTI
progression and have thus impeded substantial progress in this
area of UPEC pathogenesis research. To circumvent this obstacle,
previous studies took advantage of in vitro screening assays targeting extracellular biofilm formation or assessed the expression of
known virulence factors (hlyA, chuA, sitA, ybtS, iron, iroB, entE,
entF, fepA, exbB, tonB, feoA, and ompA) during IBC development
via quantitative PCR (qPCR) (19–21). In addition, several studies
have probed the metabolic requirements of UPEC during acute
UTI and their results have converged to suggest that UPEC bacteria require aerobic respiration and completion of the tricarboxylic
acid (TCA) cycle (despite UPEC strains being facultative anaerobes) and that UPEC primarily rely on amino acid utilization
during acute UTI (22–24).
In this study, we utilized a microarray-based approach to perform a genome-wide transcriptional profiling of UPEC 6 h postinoculation (hpi) into the mouse bladder. At that time point, the
majority of UPEC are intracellular, with smaller proportions existing extracellularly attached to host cells or in the bladder lumen
(6, 8). Our analysis revealed that within 6 hpi, 120 genes were
differentially expressed in UPEC compared to the inoculum,
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which was grown under type 1 pilus-inducing conditions. As expected, and as previously reported, genes involved with siderophore synthesis were dramatically upregulated, indicating that
bacteria are starved for iron within the IBC (20, 24). Additionally,
several genes associated with alternative sugar metabolism processes, including lacZ and srlA, were upregulated, suggesting the
absence of glucose and the presence of nonglucose sugars for utilization. These data corroborated previous circumstantial observations of lacZ upregulation in IBCs, based on strong X-Gal (5bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) staining of
IBCs indicative of beta galactosidase activity within the intracellular bacterial community (17, 18, 25). Further characterization of
a lacZ mutant that exhibited reduced galactose utilization indicated that this mutant was defective in aspects of IBC formation
and the subsequent ability to cause chronic cystitis. Analysis of the
previously uncharacterized yeaR gene, also captured in our arrays,
revealed a role for this gene in mediating type 1 pilus production
and oxidative stress responses, suggesting a role in adherence and
invasion, as well as in responding to the innate immune response.
Our analysis of the IBC transcriptome also identified several similar transcriptional profiles found in studies that have probed the
UPEC transcriptome of bacteria collected from the urine of patients diagnosed with a UTI; however, those studies did not screen
for the presence of IBCs (26–28), which can be sloughed into the
urine, depending on the timing of the onset of IBC formation and
collection of the urine (12). Combined, our findings further our
insights into conditions within the unique intracellular niche of
IBCs and provide direction for future studies focused on the development of therapeutics targeting UPEC UTIs (both acute and
chronic/recurrent).
RESULTS

The transcriptional profile of UPEC during acute UTI. We investigated the transcriptional profile of UPEC at 6 h postinfection
in the C3H/HeN mice. Previous studies have shown that the 6 h
time point is the point at which the majority of UPEC bacteria are
participating in IBC formation within the bladder epithelial cells
(8). For our studies, mice were transurethrally inoculated with the
clinical cystitis isolate UTI89 and sacrificed 6 hpi (29). Microscopic analysis validated that IBCs with approximately the same
size and shape were present in the superficial umbrella cells of the
bladder, and gentamicin protection assays revealed that only 20%
of the total CFU recovered were luminal, whereas 80% of the
population was intracellular (see Fig. S1 in the supplemental material) (8, 25). RNA was extracted from bladders after extensive
washing to remove luminal bacteria and was DNase treated, reverse transcribed (RT), and subjected to microarray analysis using
UTI89-specific Affymetrix chips (24). For comparison, RNA was
harvested from the bacterial inoculum, which was grown statically
at 37°C, as described previously (30). Analyses, after falsedetection-rate correction, revealed a total of 120 significantly (P ⬍
0.01) differentially regulated genes, or 2.3% of the UTI89 genome.
Of these, 40 were upregulated and 80 were downregulated in the
bladder. Further analysis, using a 2-fold cutoff value for biological
significance, revealed 21 positively and 30 negatively regulated
genes (Tables 1 and 2).
Several marked differences provided insight into the conditions experienced by UPEC bacteria within the superficial facet
cells of the urothelium. For example, of the 21 transcripts whose
levels were increased in the IBC relative to the inoculum (Table 1),
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TABLE 1 Genes positively regulated 6 h postinfection
Locus

Gene name

Fold change

Functiona

UTI89_C4028
UTI89_C4030
UTI89_C3064
UTI89_C4027
UTI89_C2178
UTI89_C4033
UTI89_C1122
UTI89_C1995
UTI89_C0599

chuA

13.6170702
12.62532234
8.533024788
8.363228798
6.132778168
5.365860462
5.215178967
4.653666496
4.367933273

OM hemin receptor
Hypothetical protein
PTS, glucitol/sorbitol-specific IIC2 component
Putative hemin/Hb transport protein
Salicylate synthase
Putative periplasmic binding protein with FepB/HutB regions
Putative glucosyl transferase
Hypothetical protein
Paal_thioesterase—tetrameric acyl-CoA thioesterase with a hot dog fold and one of several
proteins responsible for PA, phenylacetic acid PA degradation in bacteria
MbtH-like protein (domain found in antibiotic synthesis proteins)
Hypothetical protein
Bacteriophage lambda lysozyme-like protein
Putative type II secretion protein GspC
Transmembrane subunit, of PBP-dependent ABC transporters involved in siderophore uptake
Hypothetical protein
Beta-D-galactosidase
Hypothetical protein
Putative resistance protein (formate/oxalate antiporter)
Hypothetical protein
Hypothetical protein
Hypothetical protein

UTI89_C0587
UTI89_C1994
UTI89_C5112
UTI89_C3386
UTI89_C1336
UTI89_C1162
UTI89_C0371
UTI89_C5139
UTI89_C4087
UTI89_C4654
UTI89_C2656
UTI89_C4032
a

srlA
chuS
ybtS
chuT
iroB
yeaR
ybdB

yoaG
ybcS2
gspC
sitD
lacZ
yhjX
hkbM

3.658836126
3.380447626
3.232487202
2.910385132
2.890235424
2.870128155
2.52590251
2.265412569
2.237949848
2.114337921
2.097069502
2.055215359

OM, outer membrane; PTS, phosphotransferase system; Hb, hemoglobin; CoA, coenzyme A; PBP, periplasmic binding protein; ABC, ATP-binding cassette.

8 are associated with iron acquisition systems, suggesting the bacteria are starved for iron in vivo (31). Previous laser capture studies
have shown that host tissue surrounding the IBC significantly upregulates genes encoding iron-scavenging proteins, demonstrating innate metabolic immunity and bacterial subversion mechanisms occurring at the host-pathogen interface surrounding the
IBC (31). Other reports have also demonstrated that iron acquisition is crucial for UPEC pathogenesis (32–34). Additionally, two
genes involved in sorbitol and galactose metabolic pathways were
upregulated. srlA encodes part of the IIC sorbitol-specific transporter subunit that is involved in sorbitol uptake. lacZ encodes
beta-galactosidase, which cleaves a linkage between galactose and
glucose for utilization of these sugars. The lacZ gene is part of the
lac operon that is tightly repressed as long as there is glucose readily available (35, 36). We had previously suspected the lack of
glucose within the IBC, given that IBCs are strongly stained by
X-Gal, which acts as a beta-galactosidase substrate, and that its
cleavage results a blue stain (25). Thus, the increased expression of
these carbon intake/utilization systems suggests that glucose availability was limited and that sorbitol and/or a beta-galactoside
might have been present at elevated levels in the area surrounding
the IBC. Finally, of the 21 genes upregulated in the IBC, 8, including the yeaR/yoaG locus, had no annotated function.
A total of 30 genes were identified as being downregulated in
IBCs relative to the inoculum; 21 of those genes were hypothetical
or of putative function (e.g., putative transporters) or are uncharacterized (Table 1). Other downregulated genes included those
involved with the synthesis and transport of the amino acids tryptophan (tnaB) and cysteine (cysE). This presumably reflects an
abundance of these particular amino acids in the intracellular environment, since both of those pathways are regulated by feedback
inhibition (37, 38). The type 1 pilus, an essential virulence factor
for UPEC in colonizing the mouse urothelium, was not differentially regulated in our IBC microarray even though these fibers
are known to be expressed and critical during IBC develop-
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ment. Thus, the level of piliation under the type 1-inducing
conditions of the inoculum is likely equivalent to the expression levels in the IBC.
Microarray results were validated by selection of a subset of
genes for qPCR analysis (see Fig. S2 in the supplemental material).
For qPCR analysis, we randomly chose 5 positively and 5 negatively regulated genes that displayed statistically significant fold
changes in the microarray analysis. This analysis confirmed the
differential regulation of these targets, albeit the fold change varied from what was observed in the microarray, presumably because qPCR is generally more sensitive to expression differences
than arrays. Interestingly, this analysis revealed that ybdB, yeaR,
and yoaG were upregulated more than 30-fold in the IBC.
Analysis of upregulated genes. Based on the degree of fold
positive change, the top 8 upregulated bacterial genes/operons not
previously associated with UTI pathogenesis, yeaR, yoaG, ybdB,
gspC, srlA, UTI89_C4030, lacZ, and UTI89_C0587, were chosen
for further study. yeaR, yeaR-yeaQ (yeaR-Q), gspC, srlA,
UTI89_C4030, lacZ, and UTI89_C0587 deletion mutants were
constructed in order to assess their effect on fitness in IBC development and UTI pathogenesis. Repeated attempts to delete the
highly upregulated ybdB gene failed, suggesting either that there is
a complicated genomic structure surrounding this gene or that it
is essential for growth of UTI89. Initially, given the dominant role
of type 1 pili in the murine cystitis model, the effect of each mutation on type 1 piliation was investigated (see Fig. S3 in the supplemental material). Type 1 piliation was measured under inducing conditions using the hemagglutination assay (30). In a
hemagglutination assay, normalized bacteria are serially 2-fold
diluted and the titer indicates the maximum dilution still capable
of agglutinating guinea pig red blood cells. Mannose acts as a
competitive inhibitor of type 1 pilus-mediated adhesion; thus,
when the hemagglutination assay is performed in the presence of
mannose, type 1 pilus-specific agglutination is inhibited. UTI89
showed a hemagglutinin (HA) titer of 28 but a titer of 21 when
®
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TABLE 2 Genes negatively regulated 6 h postinfection
Locus

Gene name

Fold change

Function

UTI89_C0970
UTI89_C3263
UTI89_C2911
UTI89_C5059
UTI89_C2208
UTI89_C2246
UTI89_C3418

ycaC
ygfK

hybA

⫺2.046942047
⫺2.056558996
⫺2.075577539
⫺2.102592326
⫺2.113388903
⫺2.166165631
⫺2.218168479

UTI89_C4757
UTI89_C4841

yieN
nrdG

⫺2.240676727
⫺2.3253116

Isochorismatase
Putative selenate reductase subunit YgfK
Hypothetical protein
Hypothetical protein with predicted transporter domains
Hypothetical protein with predicted beta-lactamase domain
Putative phosphotriesterase-related protein
Hydrogenase 2: Fe-S ferredoxin-type component; participates in the periplasmic electron-transferring
activity of hydrogenase 2
Hypothetical protein
Anaerobic ribonucleotide reductase-activating protein: activates anaerobic ribonucleosidetriphosphate reductase under anaerobic conditions
Hypothetical protein with DoxX domain
Putative transport protein
Putative fimbrial component
Hypothetical protein
Putative transporter
Hypothetical protein
Hypothetical protein
Hypothetical protein
Hypothetical protein
Microcin immunity protein
Hypothetical protein
Hypothetical protein with N-acyltransferase domain
Serine acetyltransferase: cysteine biosynthesis
SS rRNAa
Hypothetical protein
Inner membrane transporter member of the POT family of peptide transporters; probable protondependent peptide transporter function
Hypothetical protein
Hypothetical protein
Plasmid-mediated exclusion of bacteriophage T7; interacts with the F plasmid-encoded PifA protein;
inner membrane protein
Tryptophan permease TnaB
Hypothetical protein

UTI89_C4908
UTI89_C2574
UTI89_C3479
UTI89_C3769
UTI89_C4235
UTI89_C1554
UTI89_C1183
UTI89_C3868
UTI89_C2154
UTI89_P026
UTI89_C3966
UTI89_C4571
UTI89_C4147
UTI89_C0224
UTI89_C3901
UTI89_C4015
UTI89_C3759
UTI89_C3283
UTI89_C4738
UTI89_C4261
UTI89_C0760
a

yhiP

⫺2.330016629
⫺2.437463493
⫺2.451883269
⫺2.463458955
⫺2.519812232
⫺2.529382149
⫺2.627212273
⫺2.645149216
⫺2.759997253
⫺2.890429712
⫺2.915524643
⫺2.959889227
⫺2.999317444
⫺3.226337436
⫺3.240851237
⫺3.672725553

fxsA

⫺4.033641779
⫺4.709429327
⫺5.055351

yfbS
ygiL
yidE
yceO

yjaB
cysE
rrfH

tnaB

⫺6.793467107
⫺7.142857143

SS, single stranded.

mannose was present, demonstrating the presence of mannosesensitive HA (MSHA). We also analyzed these mutants for defects
in UTI pathogenesis by measuring their competitive index (CI)
against UTI89 28 days postinoculation (dpi) in the bladder and
kidneys. Mutations constructed in the hypothetical UTI89_C4030
and UTI89_C0587 genes displayed no alterations in type 1 piliation and no competitive defect (Fig. S2 and data not shown). Deletion of the type II secretion component gspC did not influence
type 1 pilus expression but did result in a small defect in kidney
colonization as previously reported (39). Mutation of srlA did not
alter type 1 pilus production but resulted in an ~50-fold competitive defect in bladder infection (see Fig. S4). The two most dramatic phenotypes gleaned from this screen involved genes yeaR
and lacZ, which were selected for further study.
Analysis of yeaR. The yeaR-yoaG locus has previously been
shown to be upregulated in response to nitrosative stress due to
its regulation by the NarL and NsrR nitrogen-sensing systems
(40). YeaR has also been shown to be upregulated when E. coli
is stressed with cadmium or acidified sodium nitrite (41, 42).
However, the biological function of these proteins has yet to be
elucidated. YeaR contains a domain similar to the S-adenosylL-methionine methyltransferase domain found in TehB that
has been shown to be involved in tellurite resistance (43). Tellurite exposure results in the generation of oxidative radicals
that damage multiple cellular processes (44). However, the ho-
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mology between these two proteins is less than 25% and may not
correlate to functional similarity. YoaG contains no conserved
domains but has been annotated as a putative oxidase. The yeaRyoaG operon is hypothesized to contain 2 other genes, UTI89_
C1993, a 40-amino-acid protein with no known domains or putative function, and yeaQ, which has no known function but is
hypothesized to be a transmembrane glycosylase-associated protein. We did not find UTI89_C1993 or yeaQ to be upregulated in
our studies.
To determine if yeaR influences the virulence profile of UPEC,
a deletion of the yeaR-yoaG 4-gene operon was constructed in the
UTI89 background, resulting in a ⌬yeaR-Q strain. This strain had
an MSHA titer that is 2-fold to 4-fold lower than that seen with
the wild type, suggesting reduced levels of type 1 pili (see Fig. S2 in
the supplemental material). Deletion of yeaR alone displayed the
same 2-to-4-fold-decreased HA titer and was used in subsequent
assays to further investigate this single gene (Fig. 1A). The HA
phenotype was restored with complementation of yeaR on a plasmid. Expression of type 1 pili is governed by the fimS promoter,
which resides on an invertible element that is oriented by recombinases to give phase ON and phase OFF states (45). We also
constructed a fimS phase-locked-ON (LIR [left inverted repeat])
UTI89 mutant, which has point mutations incorporated into its
left inverted repeat, such that the recombinases that control the
inversion of fimS can no longer reorient the fimS promoter ele-
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FIG 1 Deletion of yeaR decreases type 1 piliation. (A) Type 1 piliation was assessed via hemagglutination for UTI89 and the ⌬yeaR, ⌬yeaR comp, LIR
UTI89, and LIR ⌬yeaR mutants. (B) Relative expression levels of fimI for the UTI89 and ⌬yeaR strains were measured by qPCR. (C) Pili were counted
on 300 cells per strain. Each cell was assigned one of the general descriptors “abundant,” “moderate,” “low,” and “bald” (no pili) to represent its piliation
level. This revealed a shift to a lower piliated population in the ⌬yeaR mutant that in the UTI89 strain. The cells represented in all panels were grown
under conditions of type 1 induction. The representative data shown are from experiments performed in triplicate. Asterisks denote P ⬍ 0.05 (Student’s
t test).

ment into the OFF orientation (46). We found that the LIR fimS
mutation restored the HA titer of the ⌬yeaR mutant to wild-type
levels. We also found that transcript levels of fim, as determined by
measuring fimI, were down 4-fold in the ⌬yeaR mutant compared
to the wild-type strain, consistent with the HA findings (Fig. 1B).
Finally, counts of pili on 300 individual cells grown under type
1-inducing conditions were performed using transmission electron microscopy (TEM). This analysis revealed that the ⌬yeaR
strain displayed a shift in population, significantly increasing the
number of nonpiliated and/or slightly piliated cells compared to
the wild type (Fig. 1C). Together, the results of this analysis suggest that a deletion of yeaR causes a decrease in type 1 pilus expression in UTI89.
yeaR influences oxidative stress resistance. In an effort to determine the mechanism by which yeaR influences type 1 pilus
expression, we first sought to determine if this gene is involved in
tellurite resistance as its homology suggests. Incubation with increasing concentrations of potassium tellurite revealed no difference in survival rates between UTI89 and the yeaR strain, suggesting that this gene is not required for resistance to that specific
heavy metal (Fig. 2A). However, previously published microarrays have suggested that the yeaR locus is upregulated during
oxidative stress (41). Therefore, to determine if yeaR influences
UPEC resistance to oxidative stress, killing assays were conducted
in 0.1 M sodium phosphate containing 0.1 to 1 mM hydrogen peroxide, revealing that the ⌬yeaR strain was approximately 3-fold more
sensitive to oxidative killing than UTI89 and suggesting a protective
role in reactive oxygen sensitivity (Fig. 2B). Hydrogen peroxide-
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FIG 2 Tellurite and oxidate stress sensitivity. The indicated strains were
incubated with increasing concentrations of hydrogen peroxide (A) or
potassium tellurite (B) in combination with sodium phosphate buffer
for 1 h. Percent survival was calculated against mock-treated cells incubated under the same conditions. The representative data shown are from
experiments performed in triplicate. Asterisks denote P ⬍ 0.05 (Student’s
t test).
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FIG 3 Oxidative stress influences type 1 piliation. The indicated strains were
grown under conditions of type 1 pilus induction with the addition of 0, 5, 10,
or 20 mM H2O2 to the growth media. Hemagglutination assays were performed in duplicate. Data represent averages of results of three experiments.
Asterisks denote P ⬍ 0.05 (Student’s t test).

mediated killing is highly dependent on growth conditions. Thus, we
investigated the connections between oxidative stress and type 1 pilus
production by growing the cells under type 1-inducing conditions,
statically in LB, with sublethal concentrations (for LB growth) of hydrogen peroxide (5 to 20 mM). As seen in Fig. 3, increasing concentrations of hydrogen peroxide resulted in an 8-fold decrease of HA
titers of UTI89 in 20 mM hydrogen peroxide. Deletion of yeaR amplified this effect, resulting in a 64-fold decrease in HA titers in 20 mM
hydrogen peroxide. However, LIR UTI89 restored type 1 piliation of
all strains. Taken together, these data imply that yeaR is involved in
resistance to oxidative stress and that oxidative stress results in a reduction of type 1 pilus expression due to orientation of the fimS promoter into the OFF position. Therefore, yeaR indirectly affects type 1
pilus expression by contributing to the modulation of oxidative
stress, which is then sensed by an as-yet-undetermined regulator that
modulates the fimS switch, thus influencing transcription and production of type 1 pili.
Decrease in virulence of the ⌬yeaR strain is due to decreased
type 1 piliation. yeaR is highly upregulated in UPEC at the midpoint of IBC formation (6 h). To determine if yeaR influenced IBC
development and UTI pathogenesis, separately from its effects on
type 1 piliation, we inoculated mice transurethrally with each of
the UTI89, ⌬yeaR, LIR ⌬yeaR, and LIR UTI89 strains and examined IBC formation and CFU at 6 hpi. IBCs were quantitated using
a previously described LacZ staining protocol wherein bladders

FIG 5 Type 1 pilus-mediated invasion. The UTI89, ⌬yeaR, ⌬fimA-H (⌬fim),

LIR UTI89, or LIR ⌬yeaR strain was added to the 5637 human bladder epithelial cell line and allowed to invade for 2 h. Subsequent gentamicin treatment
and cell lysis allowed the enumeration of internalized bacteria. Asterisks denote P ⬍ 0.05 (Student’s t test).

are splayed and stained with an X-Gal solution to visualize punctate blue spots representing IBCs (7). The ⌬yeaR mutant formed
significantly fewer IBCs and CFU per bladder than wild-type
UTI89. However, the presence of LIR fimS restored these defects,
arguing that the primary cause of the decreased fitness of the
⌬yeaR mutant is decreased type 1 pilus expression (Fig. 4). Our
finding that the ⌬yeaR strain had a 2-fold deficiency in invasion of
5637 bladder cells that was restored to wild-type levels by utilizing
the LIR ⌬yeaR strain or the LIR UTI89 strain was consistent with
this conclusion (Fig. 5). As a negative control, a type 1 pilus deletion, fimA-H, strain was shown to be incapable of invading these
cells, confirming that invasion is type 1 pilus dependent. Thus, the
decreased levels of type 1 pili seen with the ⌬yeaR strain result in
fewer attachment/invasion events when it is introduced into the
bladder, which in turn attenuates IBC formation.
Defects in galactose metabolism impair IBC development
and reduce the incidence of chronic infection. The lacZ gene was
also found to be significantly upregulated during IBC development. This is consistent with our finding that X-Gal stains IBCs a
punctate blue, arguing that lacZ is highly expressed (7, 25). The
⌬lacZ mutation had no effect on type 1 piliation as determined by
hemagglutination assay or invasion of 5637 cells (see Fig. S2 and

FIG 4 Year influences 6-h IBCs and colonization. C3H/HeN mice were infected for 6 h with 1 ⫻ 107 bacteria of the indicated strains. Displayed data are
representative of total bladder colonization (A) or IBC enumeration by LacZ staining (B) (n ⫽ 5 to 9). Asterisks denote P ⬍ 0.05 (Mann-Whitney t test).
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FIG 6 LacZ strain colonization and IBC formation (6 h). C3H/HeN mice were infected for 6 h with 1 ⫻ 107 UTI89 or ⌬lacZ mutant bacteria. Bladders were
either homogenized for CFU enumeration (n ⫽ 8) (A) or stretched and fixed for IBC counting using confocal microscopy (n ⫽ 5) (B). GFP-expressing strains
were used for the IBC counts. The asterisk denotes P ⬍ 0.05 (Mann-Whitney t test).

S5 in the supplemental material). Thus, the effect of the ⌬lacZ
mutation on IBC formation and UPEC virulence was assessed at
6 hpi. In single infection, the growth of the ⌬lacZ strain was attenuated, resulting in significantly fewer CFU at 6 hpi than seen with
UTI89. To investigate the effect of the ⌬lacZ mutation on IBC
formation, strains were transformed with pANT4GFP so that IBC
formation could be quantified using confocal microscopy (25).
While the ⌬lacZ strain trended toward producing slightly, but not
significantly, fewer IBCs (Fig. 6B), a microscopic and dimensional
analysis using Volocity software revealed that the ⌬lacZ IBCs at
6 hpi were distinctly smaller (average volume of 1,458 m3) than
those formed by the wild-type strains (average volume of 4,173 m3)
(Table 3). This suggests that beta-galactosidase plays a role in the
intracellular growth of bacteria and/or in the maturation of IBCs.
Given that LacZ breaks the glycosidic bond of a galactoside for its
utilization, we hypothesized that galactose metabolism may be
important during IBC development. Thus, this was investigated
by generating a ⌬galK strain, which blocks the conversion of galactose to glucose for metabolic use. In the murine cystitis model,
the ⌬galK mutant displayed a phenotype remarkably similar to
that of the ⌬lacZ strain at 6 hpi: smaller IBCs with dimensions
(1,297 m3) analogous to those of the ⌬lacZ strain (Fig. 7 and
Table 3). It has been previously shown that wild-type IBCs reach
maturation at 16 hpi and that bacteria within the IBC begin to
filament just prior to their dispersal (8, 25). In contrast to UTI89,
IBCs formed by ⌬lacZ and ⌬galK strains were completely devoid
of filaments at that time point (Fig. 7) but were instead continuing to mature in size to between 4,500 and 5,500 m3 (Table 3)

with no significant difference between strains. Thus, disrupting
galactose metabolism results in slower IBC maturation.
Urine and the UT are traditionally considered to be nutrientlimiting environments with relatively low levels of available sugars/metabolites. As such, we sought to determine if galactose metabolism was important in other stages of cystitis outside the IBC.
To address this, we conducted competitive infections using comparisons of the ⌬lacZ and ⌬galK strains to wild-type UTI89. When
inoculated in numbers equal to those of UTI89, both the ⌬lacZ
mutant and the ⌬galK mutant were significantly outcompeted
during chronic infection (Fig. 8A and B). A significant defect was
most clearly demarcated at the later stages of infection, suggesting
that galactose metabolism is important during the maintenance of
chronic infection. The ⌬lacZ and ⌬galK mutants began to be outcompeted by UTI89 after 2 weeks postinfection (average log CI,
⬎1) and after 28 dpi were present at 1,000-fold fewer CFU in the
bladder than UTI89. These data demonstrate that galactose me-

TABLE 3 Results of microscopic and dimensional analysis
Vol (m3)
Time point (h)

UPEC strain

Avg

Median

SD (m3)

P value

6

UTI89
⌬lacZ
⌬galK

4,173.8
1,458.3
1,297.6

3,735.6
551.5
919.1

2,538.7
1,735.6
1,439.4

NA
0.008
0.001

UTI89
⌬lacZ
⌬galK

5,501.9
4,541.4
5,058.4

5,159.3
3,099.3
4,726.7

4,012.3
3,809.5
3,510.2

NA
0.599
0.800

16

a

NA, not applicable.
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FIG 7 IBC comparisons (6 and 16 h). Representative micrographs depicting

GFP-expressing UTI89 and ⌬lacZ and ⌬galK mutant IBCs at 6 (top panel) or
16 (bottom panel) h postinfection. UTI89 formed significantly larger IBCs at
6 h than either mutant. At 16 h postinfection, UTI89 begins to filament just
prior to dispersal. No filaments were observed at this time point with either the
⌬lacZ mutant or the ⌬galK mutant. Images were taken from 5 different mice
for each strain.
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FIG 8 The ⌬lacZ and ⌬galK mutations confer a fitness advantage during chronic cystitis. C3H/HeN mice were infected with equal numbers of differentially

marked strain UTI89 bacteria in competition with ⌬lacZ or ⌬galK mutant bacteria. The log competitive indexes of UTI89 versus the ⌬lacZ strain (A) and UTI89
versus the ⌬galK strain (C) were determined in titers of each strain from urine samples collected 1, 3, 7, 10, 14, 21, and 28 days postinfection. Each line represents
a single mouse. Log CIs are also displayed for the bladder and kidneys of mice infected with the UTI89 or ⌬lacZ strain (B) or the UTI89 or ⌬galK strain (D).
UTI89/UTI89 (wt/wt) control competition is also shown (B and D). WT, wild type. Asterisks denote P ⬍ 0.05 (Mann-Whitney t test).

tabolism is important for the dynamics of IBC formation and in
the maintenance of chronic cystitis.
DISCUSSION

UPEC association within the host and its ability to establish and to
progress to cause UTI involve complex population dynamics between different intracellular and extracellular niches and body habitats, including (i) occupation and maintenance of a reservoir in the
gastrointestinal tract (GIT); (ii) colonization of the bladder epithelial
surface; (iii) invasion into the urothelial cytoplasm, where rapid replication occurs; and (iv) colonization of the ureters and kidneys (6,
47–50). Thus, UPEC strains must be able to deftly change their expression profile in response to their surrounding microenvironment.
Importantly, understanding the UPEC transcriptome during UTI requires consideration of the temporal and spatial niches within the
urinary tract that UPEC occupy.
Previous transcriptional analyses of bacteria isolated from the
urine of patients with UTI provided valuable insights into the transcriptome of UPEC (27, 28). However, urine likely contains variable
UPEC populations, including planktonic bacteria in the urine itself as
well as bacteria adhered to or inside sloughed epithelial cells. In addition, the composition of urine varies depending on the nutritional
status of the individual and can therefore influence the expression
profile of the bacteria growing in the urine. These variables likely
explain some of the dramatic variation that has been observed in
transcriptional analyses of urine samples. For example, levels of expression of type 1 pili in urine have been shown to differ between
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different human patients, between individual mice, and between
mice and humans (51–53). Such inconsistencies are likely due to differences in the proportions of planktonic bacteria versus bacteria adherent to or present in IBCs within sloughed epithelial cells in the
different urine samples. Human urine contains factors that specifically inhibit both expression and function of type 1 pili (54, 55).
Planktonic growth in urine induces a phase OFF orientation of the
fim promoter, thus preventing fim expression. Urine also contains
inhibitors of FimH function, and the resultant inhibition leads to a
further bias in orienting the fim promoter toward the phase OFF state
(55). However, surface association via type 1 pili favors the phase ON
state. While the analysis of the transcriptome of luminal UPEC bacteria has advanced our understanding of UPEC biology, the present
study has determined the transcriptional profile of intracellular
UPEC, which represents a critical step in the UPEC pathogenic cascade in the bladder.
It is generally hypothesized that factors necessary for the occupation of a niche may be identified by determining those genes
which are transcriptionally active in the relevant niche. In humans, collecting bladder biopsy specimens during a UTI is generally contraindicated due to the possibility of increasing the
incidence of bacteremia; thus, a thorough analysis of the transcriptional profile of intracellular UPEC requires the application of model systems. In this study, we pursued the transcriptome of the IBC since it one of the unique bacterial niches that
UPEC occupies in the urinary tract and is influential in the establishment of cystitis (6). These intracellular communities are tran-
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sient and undergo several distinct morphological changes
throughout their development (8). IBCs are biofilm-like aggregations of bacteria, in comparison to the planktonic bacteria in
urine, requiring various surface structures such as type 1 pili, capsule, and OmpA for their formation (6, 21, 56). Therefore, in an
attempt to further identify the factors necessary for the establishment of IBCs, we conducted a microarray analysis to elucidate the
transcriptional profile of UPEC during mid-IBC growth at 6 hpi
and to thereby provide insights into the conditions experienced by
the bacteria within the superficial epithelial cells of the bladder. In
addition to identifying genes that contribute to IBC development,
this analysis also revealed functions that are important for fitness
during chronic cystitis, suggesting a role for identified genes in
multiple UT niches.
Our examination of the transcriptome of tissue-associated
IBCs revealed the upregulation of factors such as galactose metabolism, the yeaR locus, and iron acquisition. Interestingly, in a recent study that examined the transcriptional profile of bacteria in
urine taken from women experiencing UTI, many of the same
systems were also found to be differentially regulated (26). These
similarities include the upregulation of iron acquisition systems
and of type II secretion as well as, in some cases, the upregulation
of lacZ, galK, and the yeaR operon (26, 28). As previously seen for
type 1 pilus expression, the expression patterns of lacZ, galK, and
the yeaR operon were not universally conserved in the 5 UPEC
isolates examined in that recent study (26). However, our work
here shows that these factors are important in IBC development
and the presence of IBCs was not evaluated in the human urine
samples studied. The presence of IBCs in human specimens is
variable depending on a multitude of factors, including the progression of the infection and the state of exfoliation of the bladder
epithelium, as IBCs form only during the acute stages of infection
in the terminally differentiated superficial umbrella cells (12, 13,
26). Results similar to those found in the current study were found
in mice in a previous study, which examined the UPEC transcriptome from mouse urine samples mostly collected within the first
24 h of infection, a time period during which numerous sloughed
bladder cells containing IBCs are typically present (57).
In experimental infections, UPEC bacteria introduced into the
bladder quickly invade the superficial epithelial cells during the
first 15 min of infection and begin the IBC cycle (58). Further, at
early acute time points (1 to 12 hpi), when micturition and exfoliation result in clearance of the vast majority of inoculated bacteria, the proportions of bacteria remaining are dominated by intracellular and/or tissue-associated bacteria (3), which have been
shown to become the founder population of the infection by replication in IBCs (7). Here, and in previous RT-PCR analysis, we
have shown that siderophore systems are upregulated in firstround IBCs as well as during growth in urine. Thus, given the early
invasion of UPEC into the epithelium and the subsequent rapid
growth of the bacteria within IBCs, it is likely that the IBC environment represents a critical trigger for the upregulation of siderophores during UTI (20). This underscores the importance of
the IBC cycle in that this niche not only provides protection from
the host immune response but also primes the bacteria for extracellular existence in urine.
Our approach to examining the tissue-specific, IBC-enriched
transcriptome also revealed alternative metabolic pathways that
the UPEC must be utilizing to fulfill its metabolic requirements in
the intracellular compartment. One of the key metabolic findings
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from this study is that glucose is not the primary sugar source
within the IBC, as evidenced by the upregulation of lacZ. The lacZ
operon is under tight regulatory control (35). This operon is composed of four genes, lacI, lacZ, lacY, and lacA (59). These genes
encode the transcriptional repressor, ␤-galactosidase, lactose permease, and galactoside O-acetyltransferase, respectively. Expression of the lac operon requires the presence of lactose or a
␤-galactoside to bind an allosteric site on LacI that alters its conformation, decreasing its affinity for DNA and thus relieving repression of RNA polymerase activity at the lac promoter (36). A
second condition that must be met for lac transcription is that
glucose levels must be low in the cell. Low-glucose conditions
result in high levels of cyclic AMP (cAMP), which binds catabolite
activator protein, allowing it to bind the lac promoter and recruit
RNA polymerase to transcribe the operon (60). Given that this
operon is extremely well characterized and that the input signals
are well known, we infer that glucose levels are low within the IBC
at 6 hpi and that lactose or a ␤-galactoside is present. This corroborates previous observations indicating that glycolysis is not essential for UPEC pathogenesis but that gluconeogenesis, TCA cycle completion, and amino acid metabolism are all crucial (23,
24). Additionally, lacZ induction is closely associated with galactose utilization, most likely due to LacZ cleaving a galactoside and
releasing free galactose, which can then be metabolized by UPEC
in an otherwise glucose-limiting environment. The requirement
of galactose metabolism for IBC development was confirmed by
showing that a galK deletion mutant (GalK is an enzyme critical
for the conversion of galactose to metabolically usable glucose)
was attenuated for IBC formation. Additional evidence for low
glucose levels in the IBC environment is that sorbitol intake systems were also upregulated in our analysis. Sorbitol has been reported to be utilized by bladder epithelial cells to regulate the
osmotic tension between the epithelium and urine and is crucial
for the maintenance of the cell volume in superficial facet cells
(61). Therefore, UPEC may be utilizing this highly concentrated
sugar alcohol as a metabolite within the IBCs formed in superficial
bladder epithelial cells. Deletion of srlA, which is involved in sorbitol import, resulted in a significant competitive defect. This suggests that having the ability to process this sugar alcohol provides
a fitness advantage to UPEC within the UT. Together, these genetic manipulations and transcriptome profiles have revealed
limited-glucose conditions during IBC development and a switch
of UPEC metabolism to use galactose and, to some extent, sorbitol, which, in comparison to glucose, requires extra enzymatic
processing before it can be metabolized.
Chronic cystitis in mice develops after a week or more of infection and is defined by unchecked luminal bacterial replication and
urothelial hyperplasia and the presence of submucosal lymphoid
aggregates, a histological pattern similar to that seen in humans
suffering chronic UTI (15). The extracellular niche occupied by
UPEC during chronic cystitis is thus distinct from the intracellular
environment of the IBC that is protected from the immune response. However, we found that both the lacZ mutants and the
galK mutants were dramatically outcompeted by UTI89 during
chronic cystitis. It is unlikely that this phenotype can be attributed
solely to slower IBC development, since there was no noticeable
competitive defect during the first week of competition. This outcompetition during chronic cystitis suggests that the level of sugar
metabolites may be limiting during chronic cystitis and that cells
able to utilize ␤-galactosides/galactose are more fit in this environ®
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ment. Alternately, it is also possible that this pathway is necessary
for the assembly of a UPEC virulence determinant. This has been
observed previously in Bacillus subtilis, where galactose metabolism is essential for the assembly of the exopolysaccharide component of the biofilm matrix, a crucial component of pathogenesis
(62). While we cannot discount the possibility that galactose metabolism is influencing biofilm formation or polysaccharide synthesis in vivo, mutations in lacZ and galK did not alter in vitro
biofilm formation under the standard LB-polyvinyl chloride plate
conditions tested (data not shown).
A second theme discovered through our microarray analysis
was that UPEC is also responding to oxidative stress as evidenced
by yeaR being one of the most highly upregulated genes in the IBC.
yeaR expression has been shown to be induced by heavy metals,
which induce oxidative stress, and by reactive nitrogen species (40,
41). Here we show that this gene is involved in resistance to oxidative stress in UPEC and that this oxidative stress influences type
1 pilus expression, thereby attenuating acute pathogenesis. The
interconnectedness between oxidative stress and type 1 pilus expression/production has also been documented with IbeA and
RpoS (63, 64). Further demonstrating this interconnectedness,
bacteria bound to agarose beads in a type 1 pilus-dependent manner displayed a modest upregulation of both the SoxS and OxyR
systems in a transcriptional study (65). Additionally, work by Crespo et al. demonstrated that a proper oxidative state of the FimA
major pilus subunit is necessary for recognition by the FimC chaperone and subsequent pilus assembly, underscoring the potential
effects of oxidative imbalances on pilus biogenesis (66). While
higher levels of oxygen tension and oxidative stress are detrimental to type 1 pilus production, the presence of at least some oxygen
is required for pilus production. Recent work by Floyd et al. demonstrated that type 1 pili are expressed only in biofilm regions
exposed to oxygen (67). Taken together, these data suggest an
increasingly evident balance between oxidative stress/sensing
mechanisms and type 1 pilus production. Further, UPEC bacteria
have evolved mechanisms to overcome this pressure and thus to
maintain virulence in hostile environments. Understanding this
connection will better elucidate the signals that control type 1
pilus production and UPEC virulence.
Together, these results provide insights into the nutrient and
stress conditions faced by UPEC within the IBC. Determining
what environmental responses UPEC bacteria mount and what
bacterial factors they display during the very early stages of infection will allow the development of therapeutics that could potentially inhibit the establishment of UTI and thereby reduce the
occurrence of this highly prevalent infection.
MATERIALS AND METHODS
RNA extraction and microarray analysis. A total of 15 C3H/HeN mice
were inoculated transurethrally with 1 ⫻ 108 CFU of UTI89 for 6 h. Bladders were aseptically removed and gently washed with phosphatebuffered saline (PBS) to remove extracellular bacteria. Immediately following washing, 3 groups of 5 bladders each were homogenized with 1 ml
Tris-EDTA (TE)–100 g/ml lysozyme and immediately transferred to
1.5 ml of RLT RNA extraction buffer (Qiagen) before mechanical shearing
was performed using bead beating and silica beads (two 1-min beadbeating intervals). Homogenates were centrifuged at 10,000 rpm and 4°C
for 10 min, and cellular lysates were treated for RNA isolation using columns and reagents from an RNeasy kit (Qiagen). Following extraction,
eukaryotic RNA was removed using a MICROBEnrich kit (Ambion) and
the remaining “enriched” bacterial RNA was treated with DNase. Exoge-
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nous RNA spikes were then added as internal controls for RT and labeling
reactions. Resulting cDNA samples were fragmented, biotinylated, and
hybridized to GeneChip custom-made genome arrays (Affymetrix
UTI89-01a520299F). Data analysis was performed using ArrayStar software. Data were preprocessed using robust microarray analysis (RMA) to
eliminate the effects of probe-specific hybridization differences and then
normalized using PLYER with a statistical P cutoff of ⬍0.01. qPCR was
performed as previously described (68) using primers listed in Table S1 in
the supplemental material.
Strains and plasmids. The cystitis isolate UTI89 was utilized as the
wild-type isolate for this study (29). Deletions of yeaR, yeaR-Q, gspC, srlA,
UTI89_C4030 and UTI89_C0587, lacZ, and galK were constructed using
a  Red recombinase system and by disruption of the target gene by insertion of a kanamycin cassette (see Table S1 in the supplemental material) (69). All green fluorescent protein (GFP) isolates contained the
pANT4 GFP-expressing plasmid which has previously been used in
UTI89 (70). Complementation of yeaR was accomplished by cloning this
gene and its promoter region into the pBAD33 plasmid using BamH1 and
HindIII in the orientation opposite that of the arabinose promoter to
facilitate native levels of expression (see Table S1).
Hemagglutination. Type 1 pilus production was assayed by hemagglutination assay as described previously by Hultgren et al. (53).
Electron microscopy. Strains were cultured as described for the
mouse infections and were prepared for electron microscopy as described
by Rosen et al (71). Briefly, bacteria were absorbed onto Formvar-carboncoated copper grids for 1 min. Grids were washed in distilled water and
stained with 1% aqueous uranyl acetate (Ted Pella Inc.) for 1 min. Images
were obtained using a JEOL 1200EX transmission electron microscope
(JEOL USA).
qPCR. RNA was harvested either from two 24-h (2 ⫻ 24) cultures or in
vivo using an RNeasy kit (Qiagen) as discussed above. Samples were
DNase treated before reverse transcription was performed as described
previously (68). qPCR was performed with cDNA utilizing a Sybr green
system (BioRad) to determine threshold cycle (CT) values, which were
then used to calculate relative fold changes using the ⌬⌬CT method (68).
Invasion assays. Bladder epithelial cells of the 5637 cell line (ATCC
HTB-9) were seeded into 24-well plates and grown to ~80% confluence,
as determined microscopically, in RPMI medium supplemented with
10% fetal bovine serum. Bacteria were then added to the medium at a 10:1
bacterium/host cell ratio for 2 h at 37°C. The medium was then removed
and replaced with fresh medium containing 100 g/ml gentamicin for an
additional 2 h. Spent medium was then removed, and the cells were
washed 3 times with PBS followed by lysis with 0.1% Triton X-100. Lysates
were then plated on LB plates for bacterial enumeration. Experiments
were performed in triplicate.
Mouse infections. In preparation for inoculation into mice, UPEC
strains were grown statically in LB at 37°C overnight and then subcultured
at a dilution of 1:1,000 into 10 ml of fresh LB for a second static outgrowth
performed at 37°C for 18 to 24 h. From these cultures, 1 ⫻ 107 bacteria
suspended in PBS were inoculated into lightly anesthetized C3H/HeN
mice transurethrally in a 50-l injection. Infections proceeded from 6 h to
28 days before sacrifice was performed using anesthesia, and the bladders
and kidneys were removed and homogenized in sterile PBS. Homogenates
were plated for bacterial enumeration. Competitive infections were initiated by mixing 1 ⫻ 107 bacteria from each strain into the inoculum.
Coinoculated strains carried different antibiotic markers, which allowed
the tracking of bacterial titers of the individual strains throughout the
time course. Each experiment was repeated in duplicate with separately
isolated clones of the noted strains.
IBC analysis. At 6 hpi, mice were sacrificed and bladders aseptically removed and splayed for IBC enumeration by lacZ staining (7). Alternately, IBC
counts for the lacZ mutants were determined using GFP-expressing bacteria
and confocal microscopy (Zeiss LSM 510). Confocal images were volumetrically analyzed using Volocity software (PerkinElmer).
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Bacterial killing assays. The indicated UPEC strains were grown under shaking conditions to an optical density at 600 nm (OD600) of 1.
Bacteria were then diluted to approximately 1 ⫻ 106 cells/ml in 0.1 M
sodium phosphate. Hydrogen peroxide was added at the designated concentrations followed by incubation for 1 h at 37°C before cells were serially
diluted and plated to determine percent survival. Tellurite killing assays
were performed similarly with the indicated concentrations of potassium
tellurite incubated with bacteria for 1 h at 37°C followed by serial dilution
and plating.
Hydrogen peroxide hemagglutination assays. Cells were grown as
described for mouse infection except for the addition of the indicated
concentrations of hydrogen peroxide into the culture at time of inoculation. After 24 h of growth at 37°C, bacteria were subcultured with fresh
hydrogen peroxide for an additional 24 h. Bacterial numbers were standardized via optical density and colony enumeration to ensure that similar viable-cell numbers were used for the hemagglutination assay described above.
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